Santhera Pharmaceuticals announced the appointment of Stephanie Brown as President North America and a member of Santhera?s Executive Management team, effective December 1, 2021. Stephanie Brown joins Santhera with an extensive background leading commercial businesses and global franchises in North America and Europe. Most recently, she was Senior Vice President and Head of the Rare Diseases Franchise, North America at Ipsen Pharmaceuticals. In this role, she was responsible for establishing a new rare disease business unit to market and launch medicines to treat rare conditions.